Evogene LTD (EVGN) Market Value Declined While Moon Capital Management LP Increased by $424,364 Its Stake; As Intercept Pharmaceuticals In (ICPT) Shares Declined, National Planning Has Boosted by $632,490 Its Holding

February 17, 2018 - By Vivian Park

John W. Moon increased its stake in Evogene Ltd (EVGN) by 40.94% based on its latest 2017Q3 regulatory filing with the SEC. Moon Capital Management Lp bought 106,091 shares as the company’s stock declined 3.83% while stock markets rallied. The hedge fund run by John W. Moon held 365,202 shares of the agricultural chemicals company at the end of 2017Q3, valued at $1.62M, up from 259,111 at the end of the previous reported quarter. Moon Capital Management Lp who had been investing in Evogene Ltd for a number of months, seems to be bullish on the $94.55 million market cap company. The stock decreased 1.83% or $0.07 during the last trading session, reaching $3.75. About 7,747 shares traded. Evogene Ltd. (NYSE:EVGN) has declined 23.47% since February 17, 2017 and is downtrending. It has underperformed by 40.17% the S&P500.

National Planning Corp increased its stake in Intercept Pharmaceuticals In (ICPT) by 20.89% based on its latest 2017Q3 regulatory filing with the SEC. National Planning Corp bought 10,905 shares as the company’s stock declined 12.60% while stock markets rallied. The institutional investor held 63,100 shares of the health care company at the end of 2017Q3, valued at $3.66 million, up from 52,195 at the end of the previous reported quarter. National Planning Corp who had been investing in Intercept Pharmaceuticals In for a number of months, seems to be bullish on the $1.54 billion market cap company. The stock increased 0.86% or $0.52 during the last trading session, reaching $61.16. About 714,838 shares traded. Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) has declined 14.52% since February 17, 2017 and is downtrending. It has underperformed by 31.22% the S&P500.

National Planning Corp, which manages about $1.20 billion US Long portfolio, decreased its stake in Select Sector Spdr Tr (XLE) by 24,124 shares to 17,764 shares, valued at $1.22M in 2017Q3, according to the filing. It also reduced its holding in Vanguard Scottsdale Fds (VONV) by 7,650 shares in the quarter, leaving it with 6,899 shares, and cut its stake in Powershares Etf Tr Ii (EELV).

Among 23 analysts covering Intercept Pharmaceuticals (NASDAQ:ICPT), 12 have Buy rating, 3 Sell and 8 Hold. Therefore 52% are positive. Intercept Pharmaceuticals had 73 analyst reports since August 10, 2015 according to SRatingsIntel. The stock has “Sell” rating by Cantor Fitzgerald on Tuesday, September 12. The firm earned “Market Perform” rating on Wednesday, October 4 by JMP Securities. On Wednesday, February 24 the stock rating was maintained by Barclays Capital with “Overweight”. JMP Securities maintained it with “Market Outperform” rating and $200 target in Tuesday, May 31 report. Cowen & Co maintained the shares of ICPT in report on Tuesday, September 12 with “Buy” rating. The rating was downgraded by Oppenheimer to “Perform” on Friday, September 22. The firm has “Buy” rating given on Monday, July 31 by Oppenheimer. Cowen & Co maintained the stock with “Buy” rating in Monday, July 31 report. The firm has “Hold” rating given on Tuesday, February 13 by Wells Fargo. Morgan Stanley upgraded Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) rating on Friday, January 29. Morgan Stanley has “Equal-Weight” rating and $100 target.

Investors sentiment decreased to 1.33 in 2017 Q3. Its down 0.26, from 1.59 in 2017Q2. It is negative, as 33 investors sold ICPT shares while 30 reduced holdings. 30 funds opened positions while 54 raised stakes. 18.23 million shares or 10.01% less from 20.26 million shares in 2017Q2 were reported. Millennium Mngmt Limited Liability Company holds 0.01% or 88,819 shares in its portfolio. Eulav Asset Mgmt invested in 0.18% or 66,000 shares. 31,596 are owned by Jane Street Grp Inc Limited Liability. Jefferies Grp Limited owns 258,759 shares. Moreover, Barclays Public Limited Com has 0% invested in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT). Illinois-based Columbia Wanger Asset Mgmt Ltd has invested 0.09% in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT). Moreover, Voya Management Ltd Limited Liability Company has 0% invested in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT). Wells Fargo Mn, a California-based fund reported 93,910 shares. Orbimed Advisors Limited holds 0.21% or 386,380 shares. Swiss Bank & Trust invested 0% in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT). Metropolitan Life holds 0% in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) or 1,350 shares. Bb Biotech Ag holds 0.78% or 485,719 shares. Sg Americas Ltd Llc has 0.01% invested in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT). Gru One Trading LP invested in 15,278 shares. Vantage Inv Ltd Liability Company holds 55 shares or 0% of its portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Vivian Park

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: